| 000 | 01809 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513135610.0 | ||
| 264 | 0 | _c19980429 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0934-9723 | ||
| 024 | 7 |
_a10.1007/BF01700553 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurke, M | |
| 245 | 0 | 0 |
_aCytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cDec 1997 |
||
| 300 |
_a876-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xcytology |
| 650 | 0 | 4 |
_aCytomegalovirus Retinitis _xepidemiology |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aYust, I | |
| 700 | 1 | _aKatlama, C | |
| 700 | 1 | _aVardinon, N | |
| 700 | 1 | _aClumeck, N | |
| 700 | 1 | _aPinching, A J | |
| 700 | 1 | _aLedergerber, B | |
| 700 | 1 | _aGatell, J M | |
| 700 | 1 | _aChiesi, A | |
| 700 | 1 | _aBarton, S E | |
| 700 | 1 | _aLundgren, J D | |
| 700 | 1 | _aPedersen, C | |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 16 _gno. 12 _gp. 876-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01700553 _zAvailable from publisher's website |
| 999 |
_c9463776 _d9463776 |
||